Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2021-06-15 Board/Management Inform…
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
Appointment of Joint Broker
Board/Management Information Classification · 99% confidence The document begins with 'RNS Number : 8605B' and is dated '15 June 2021'. It announces the 'Appointment of Joint Broker' for Scancell Holdings Plc. This type of announcement, which details changes in professional advisors (brokers, nominated advisers) or other material corporate news released via the Regulatory News Service (RNS) of the London Stock Exchange, fits best under the general regulatory announcement category. Since it is not a formal financial report (10-K, IR, ER), a specific corporate action (CAP, SHA, POS), or management change (MANG), the most appropriate classification is the general regulatory filing fallback, RNS.
2021-06-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1935 characters) and contains the header 'RNS Number : 2232B'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory event notification. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' Since this is a specific, short regulatory announcement that doesn't fit the definitions for ER, IR, 10-K, or any other specific report type, and it is clearly distributed via the RNS system, the most appropriate classification is the general regulatory filing category.
2021-06-08 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a very brief announcement regarding a 'Price Monitoring Extension' for a security, which is a routine market operational update rather than a comprehensive financial report (like 10-K or IR) or a specific corporate action (like DIV or CAP). Given its nature as a short, routine regulatory notification disseminated via the RNS system, the most appropriate classification is the general regulatory filing category.
2021-06-08 English
Director Dealing
Director's Dealing Classification · 99% confidence The document is an official announcement from Scancell Holdings Plc, identified by the 'RNS Number' header and the closing statement referencing RNS, the news service of the London Stock Exchange. The core content is titled 'Director Dealing' and details the purchase of ordinary shares by a person closely associated with a Non-Executive Director (Martin Diggle). This transaction reporting by insiders (directors/executives) falls directly under the definition of Director's Dealing. The corresponding code is DIRS.
2021-06-07 English
Director Dealing
Director's Dealing Classification · 100% confidence The document is an official announcement from Scancell Holdings Plc, identified by the RNS Number and the use of the RNS distribution service header. The core content explicitly states 'Director Dealing' and provides detailed tables regarding a 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Therefore, the filing type is DIRS.
2021-04-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 7877R' and contains the standard formatting for a regulatory notification disseminated via RNS (Regulatory News Service). Specifically, the form title is 'TR-1: Standard form for notification of major holdings'. This form reports changes in significant share ownership, which corresponds directly to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2021-03-10 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.